Effect of tetramethylpyrazine on DRG neuron P2X3 receptor involved in transmitting pain after burn

Burns. 2010 Feb;36(1):127-34. doi: 10.1016/j.burns.2009.04.032. Epub 2009 Sep 1.

Abstract

A burn is a severe injury, and the resulting pain can be very significant. Currently, opioids are the primary method of pain management, but these drugs have side effects; thus, it is of prime focus to research the mechanisms of pain formation and analgesic drugs.

Objective: To investigate the effects of tetramethylpyrazine (TMP) on burn pain mediated by the P2X3 receptor.

Methods: First-degree and superficial second-degree burn models were used. The mechanical withdrawal threshold (MWT) and thermal withdrawal latency (TWL) were measured, and P2X3 receptor expression on nerve terminals in burn-injured skin were detected by immunohistochemistry. The effects of TMP on the P2X receptor agonist-activated currents in freshly isolated burn-injured rat dorsal root ganglion (DRG) neurons were studied by whole-cell patch-clamp technique.

Main results: One hour following the procedure, MWT and TWL in first and second-degree paw-burns with normal saline (NS) treatment were lower than those in the unburned control group and lasted for 24 or 96 h, respectively (p<0.01). After 24 h, MWT and TWL in the first-degree paw-burn with TMP treatment were significantly increased as compared with NS treatment; no difference was found when compared to the unburned control group. MWT and TWL in the second-degree paw-burn in the TMP treatment group were significantly increased at 48 h compared to NS treatment. No difference was found with the values for the unburned control group after 72 h. On day 3 after the burn, P2X3-receptor expression in the nerve terminal in the burn-injured skin of the first- and second-degree dorsal burns in the NS treatment group was higher than those in other groups (p<0.05). After treatment with TMP, P2X3-receptor expression of the nerve terminal in the first- and second-degree dorsal burns of the TMP treatment group was significantly decreased. ATP-activated currents (IATP) on the DRG neurons of the second-degree dorsal burn in the NS treatment group were markedly higher than those in the second-degree dorsal burns in the TMP treatment group and the unburned control group (p<0.05); there were no significant differences between the second-degree dorsal burn in the TMP treatment group and the unburned control group (p>0.05).

Conclusion: TMP alleviates nociceptive transmission of burn-injury pain mediated by the P2X3 receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics, Non-Narcotic / pharmacology
  • Analgesics, Non-Narcotic / therapeutic use
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Burns / complications*
  • Burns / metabolism
  • Disease Models, Animal
  • Drug Evaluation, Preclinical / methods
  • Ganglia, Spinal / drug effects*
  • Ganglia, Spinal / metabolism
  • Hyperalgesia / etiology
  • Hyperalgesia / metabolism
  • Hyperalgesia / prevention & control*
  • Male
  • Pain Threshold / drug effects
  • Patch-Clamp Techniques
  • Pyrazines / pharmacology*
  • Pyrazines / therapeutic use
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Purinergic P2 / drug effects*
  • Receptors, Purinergic P2 / metabolism
  • Receptors, Purinergic P2 / physiology
  • Receptors, Purinergic P2X3
  • Skin / innervation

Substances

  • Analgesics, Non-Narcotic
  • Anti-Inflammatory Agents, Non-Steroidal
  • P2rx3 protein, rat
  • Pyrazines
  • Receptors, Purinergic P2
  • Receptors, Purinergic P2X3
  • tetramethylpyrazine